IP Library Granted Patent US 10,022,218
Granted Patent B2
US 10,022,218 · App. 14/622,165 · Granted Jul 17, 2018

Tricuspid regurgitation model and methods of evaluating intraluminal medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,022,218
App. No.
14/622,165
Granted
Jul 17, 2018
Kind
B2
Abstract

Animal models useful in the evaluation of medical devices, such as intraluminal medical devices, including intraluminal valve prostheses, are described. An example animal model comprises an animal in which a chordae tendineae attached to at least one of the leaflets of the tricuspid valve has been cut during an interventional procedure. Methods of evaluating intraluminal medical devices are also described. An example methods comprises cutting chordae tendineae attached to a leaflet of a tricuspid valve of an animal; allowing the animal to recover from the step of cutting the chordae tendineae; implanting an intraluminal medical device at a target site within a body vessel of the animal; allowing the animal to recover from the step of implanting an intraluminal medical device; and monitoring in vivo performance of the intraluminal medical device.

Claims (24)

1. A method of evaluating an intraluminal medical device, the method comprising:

cutting chordae tendineae attached to a leaflet of a tricuspid valve of an animal;

allowing the animal to recover from the step of cutting the chordae tendineae;

implanting an intraluminal medical device at a target site within a body vessel of the animal;

allowing the animal to recover from the step of implanting an intraluminal medical device; and

monitoring in vivo performance of the intraluminal medical device.

2. The method of claim 1 , wherein the animal comprises a sheep.

3. The method of claim 1 , wherein the step of cutting chordae tendineae comprises accessing the chordae tendineae percutaneously.

4. The method of claim 1 , wherein the step of cutting chordae tendineae comprises accessing the chordae tendineae surgically.

5. The method of claim 1 , wherein the step of implanting an intraluminal medical device comprises percutaneously implanting an intraluminal medical device.

6. The method of claim 1 , wherein the step of implanting an intraluminal medical device comprises surgically implanting an intraluminal medical device.

7. The method of claim 1 , wherein the intraluminal medical device comprises an intraluminal valve prosthesis.

8. The method of claim 1 , wherein the intraluminal medical device comprises an intraluminal venous valve prosthesis.

9. The method of claim 1 , wherein the step of implanting an intraluminal medical device is conducted prior to the step of cutting chordae tendineae.

10. The method of claim 1 , wherein the step of implanting an intraluminal medical device is conducted concurrently with the step of cutting chordae tendineae.

11. The method of claim 1 , wherein the step of implanting an intraluminal medical device follows the step of cutting chordae tendineae.

12. A method of evaluating an intraluminal medical device, the method comprising:

cutting chordae tendineae attached to a leaflet of a tricuspid valve of an animal;

allowing the animal to recover from the step of cutting the chordae tendineae;

implanting an intraluminal medical device at a target site within a body vessel of the animal;

allowing the animal to recover from the step of implanting an intraluminal medical device; and

monitoring in vivo performance of the intraluminal medical device;

wherein the step of allowing the animal to recover from the step of cutting chordae tendineae comprises allowing at least two weeks to pass between the step of cutting chordae tendineae and any subsequent step.

13. The method of claim 12 , wherein the step of allowing the animal to recover from the step of cutting chordae tendineae comprises allowing at least two weeks to pass between the step of cutting chordae tendineae and the step of implanting an intraluminal medical device.

Assignments (4)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2016
From: KRIEGER, JOSHUA; CHAMBERS, SEAN
To: COOK INCORPORATED
Reel/Frame 037654/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2016
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 037654/0801 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2016
From: BERWICK, ZACHARY; KASSAB, GHASSAN
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 037654/0923 →